Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Autor: Hadoux, J., Lamarca, A., Grande, E., Deandreis, D., Kaltsas, G., Janson, E.T., Tombal, B., Pavel, M., Thariat, J., van Velthuysen, M.F., Herman, P., Dromain, C., Baudin, E., Berruti, A.

Publikováno v: In ESMO Open October 2024 9(10)

EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses.

Autor: Pouget JP; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France. Equipe Labellisée Ligue Contre Le Cancer, INSERM U1194/IRCM, 208 Rue Des Apothicaires, 34298, Montpellier, France. jean-pierre.pouget@inserm.fr., Gabina PM; Department of Medical Physics and Radiation Protection, Gurutzeta-Cruces University Hospital/Biocruces Health Research Institute, Barakaldo, Spain., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany., Deandreis D; Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Paris Saclay University, 114 Rue Edouard Vaillant, Villejuif, France., Konijnenberg M; Radiology & Nuclear Medicine Department, Erasmus MC, Rotterdam, The Netherlands., Taieb D; Nuclear Medicine Diagnostic Imaging and Endoradiotherapy Center Aix-Marseille University CHU de La Timone, Marseille Cedex 5, Marseille, France., van Leeuwen FWB; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, the Netherlands., Kurth J; Department of Nuclear Medicine, University Medical Center Rostock, Rostock, Germany., Eberlein U; Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany., Lassmann M; Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany., Lückerath K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany. Katharina.Lueckerath@uk-essen.de.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.

Comparative Performance of ⁶⁸ Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy.

Autor: Rovera G; Nuclear Medicine Division, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Grimaldi S; Nuclear Medicine Division, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy., Oderda M; Urology Unit, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, University of Turin, 10126 Turin, Italy., Marra G; Urology Unit, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, University of Turin, 10126 Turin, Italy., Calleris G; Urology Unit, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, University of Turin, 10126 Turin, Italy., Iorio GC; Department of Oncology, Radiation Oncology, University of Turin, 10126 Turin, Italy., Falco M; Department of Oncology, Radiation Oncology, University of Turin, 10126 Turin, Italy., Grossi C; Department of Oncology, Radiation Oncology, University of Turin, 10126 Turin, Italy., Passera R; Nuclear Medicine Division, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.; Nuclear Medicine Division, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy., Campidonico G; Nuclear Medicine Division, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy., Mangia ML; Nuclear Medicine Division, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy., Deandreis D; Nuclear Medicine Division, Gustave Roussy, 94805 Villejuif, France., Faletti R; Radiology Unit, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy., Ricardi U; Department of Oncology, Radiation Oncology, University of Turin, 10126 Turin, Italy., Gontero P; Urology Unit, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, University of Turin, 10126 Turin, Italy., Morbelli S; Nuclear Medicine Division, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.; Nuclear Medicine Division, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Sep 05; Vol. 14 (17). Date of Electronic Publication: 2024 Sep 05.

Mélanomes cutanés, oculaires et des muqueuses

Autor: Déandreis, D., Salaün, P.Y.

Publikováno v: In Médecine Nucléaire January-March 2019 43(1):125-137

The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study.

Autor: Marra G; Division of Urology, Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy. Electronic address: giancarlo.marra@unito.it., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Medical University of Silesia, Zabrze, Poland., Filippini C; Division of Urology, Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy., Ploussard G; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France., Montefusco G; Division of Urology, Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy., Puche-Sanz I; Department of Urology, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain., Olivier J; Department of Urology, Lille University, Lille, France., Zattoni F; Department of Surgery, Oncology and Gastroenterology, Urology Clinic, University of Padua, Padua, Italy., Moro FD; Department of Surgery, Oncology and Gastroenterology, Urology Clinic, University of Padua, Padua, Italy., Magli A; Dipartimento di Radioterapia Oncologica, Ospedale Santa Maria della misericordia, Udine, Italia., Dariane C; Department of Urology, Hôpital européen Georges-Pompidou, Université de Paris, Paris, France., Affentranger A; University of Zurich, Zurich, Switzerland., Grogg JB; University of Zurich, Zurich, Switzerland., Hermanns T; University of Zurich, Zurich, Switzerland., Chiu PK; Division of Urology, Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong., Malkiewicz B; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology Wroclaw Medical University, Wroclaw, Poland., Kowalczyk K; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology Wroclaw Medical University, Wroclaw, Poland., Van den Bergh RCN; Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bianchi A; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Antonelli A; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Gallina S; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Berchiche W; Department of Urology, Institut Mutualiste Montsouris, Paris, France., Sanchez-Salas R; Department of Surgery, Division of Urology, McGill University, Montreal, Quebec, Canada., Cathelineau X; Department of Urology, Institut Mutualiste Montsouris, Paris, France., Afferi L; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Mattei A; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, NY., Scuderi S; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Montorsi F; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Briganti A; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Deandreis D; Division of Nuclear Medicine, Department of Medical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy., Gontero P; Division of Urology, Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy., Gandaglia G; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Apr; Vol. 22 (2), pp. 244-251. Date of Electronic Publication: 2023 Nov 17.